>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

April 21, 2014

Lidocaine HCI Injection, USP, by Hospira: Recall - Visible Particulates

Summary:

Lidocaine HCI Injection USP by Hospira Recall Visible Particulates

April 18, 2014

Propofol Injectable Emulsion, USP by Hospira: Recall - Visible Particulates

Summary:

Propofol Injectable Emulsion USP by Hospira Recall Visible Particulates

April 18, 2014

FDA MedWatch - ARKON Anesthesia Delivery System with Version 2.0 Software by Spacelabs Healthcare: Class I Recall

Summary:

FDA MedWatch Class I Recall 4 18 14

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-14CE

... Read more »

Single Copies, Member Price: $360

ASA Sends Letter Supporting S.296

Monday, February 14, 2011

 The American Society of Anesthesiologists (ASA) sent a letter to Senator Amy Klobuchar (D-MN) expressing support for S.296, the "Preserving Access to Life-Saving Medications Act."  This legislation is an important first step towards addressing the serious drug shortages facing patients and physicians today.  The ASA has been a leader on addressing drug shortages. In November, ASA co-convened a "Drug Shortages Summit" to identify the core causes of drug shortages. 

In the letter, ASA President Mark A. Warner M.D., says, "The drug shortages we have encountered during this past year have resulted in harm – even death -- to patients. Countless other near tragedies associated with these drug shortages have been averted by the skills that our anesthesiologists bring to bear every day. If enacted, your bill will help reduce the frequency and severity of these shortages, and we are very grateful."

Click here to read the entire letter. 

« Back to Washington Alerts